NASDAQ:SNSE
Sensei Biotherapeutics, Inc.
- Stock
industry
Biotechnologyexchange
NASDAQ Global Marketwebsite
www.senseibio.comipo date
Feb 04, 2021full time employees
28currency
USD
Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus